FDA Seeks Risk-Based Inspection Program

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-11-02-2003, Volume 27, Issue 11

FDA's new policies intend to make GMP inspections more efficient and apply to stricter rules to high-risk products and processes.

Related Content:

Regulatory WatchPharmaceutical Technology-11-02-2003
Industry Challenges Medicare Price Negotiation Scheme
Drug Shortages Continue to Plague FDA and Manufacturers
FDA Eyes New Strategies to Spur Gene Therapy Development